| INUTX | RMFCX | INUTX / RMFCX | |
| Total Expense Ratio | 1.03 | 0.91 | 113% |
| Annual Report Gross Expense Ratio | 1.03 | 0.91 | 113% |
| Fund Existence | 38 years | 24 years | - |
| Gain YTD | 16.963 | 9.325 | 182% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 2000 | 250 | 800% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.54B | 118B | 2% |
| Annual Yield % from dividends | 2.19 | 1.16 | 189% |
| Returns for 1 year | 19.26 | 7.69 | 251% |
| Returns for 3 years | 41.79 | 32.42 | 129% |
| Returns for 5 years | 35.00 | 37.08 | 94% |
| Returns for 10 years | 48.43 | 91.03 | 53% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| LGHT | 8.20 | 0.04 | +0.49% |
| Langar Global HealthTech ETF | |||
| VABS | 24.09 | 0.05 | +0.21% |
| Virtus Newfleet Securitized Income ETF | |||
| BRNY | 58.87 | N/A | N/A |
| Burney U.S. Factor Rotation ETF | |||
| VGRO | 24.99 | N/A | N/A |
| VIRTUS SILVANT GROWTH OPPORTUNITIES ETF | |||
| XBI | 150.48 | -1.75 | -1.15% |
| State Street® SPDR® S&P® Biotech ETF | |||